Given the growing burden of chronic diseases, and limited treatment options for rare disorders, there is a need for more safe and versatile therapeutic options and plasma derived therapies have emerged as the effective alternatives.
Driven by the growing demand for blood plasma derived therapies and the ongoing advancements in fractionation technologies, the plasma fractionation market is expected to grow at a noteworthy pace in the foreseen future.
The financial opportunity within the plasma fractionation market has been analyzed across the following segments:
§ Type of Company
§ In-house Manufacturers
§ Contract Service Providers
§ Scale of Operation
§ Preclinical
§ Clinical
§ Commercial
§ Type of Plasma-derived Therapeutic Products Manufactured
§ Albumins
§ Coagulation Factors
§ Immunoglobulins
§ Protease Inhibitors
§ Other Plasma-derived Products
§ Therapeutic Area of Plasma-derived Products
§ Hematological Disorders
§ Hepatic Disorders
§ Immunological Disorders
§ Neurological Disorders
§ Other Disorders
§ Demand across Key Geographical Regions
§ North America
§ Europe
§ Asia-Pacific
§ Rest of the World
§ Supply across Key Geographical Regions
§ North America
§ Europe
§ Asia-Pacific
§ Rest of the World
The Plasma Fractionation Market, 2023-2035 report features the following companies, which we identified to be key players in this domain:
§ Baxter
§ Grifols
§ Kedrion
§ Octapharma
§ CSL
§ Takeda Pharmaceutical
Table of Contents
1. Preface
2. Executive Summary
3. Introduction
4. Plasma Fractionation: Market Landscape
5. Company Competitiveness Analysis
6. Company Profiles
7. Partnerships and Collaborations
8. Recent Expansions
9. Capacity Analysis
10. Market Sizing and Opportunity Analysis
11. Concluding Remarks
12. Executive Insights
13. Appendix I: Tabulated Data
14. Appendix II: List of Companies and Organizations
To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/plasma-fractionation-market.html
News article
Cell and Gene Therapy CROs Market
Learn from experts: do you know about these emerging industry trends?
The Future of Drug Delivery: Exploring Large Volume Wearable Injectors
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
Русский